id	sid	eid	entity	type
asodahs-27	1	1	ahirwar et	PERSON
asodahs-27	1	2	al asian journal	ORG
asodahs-27	1	3	2022	CARDINAL
asodahs-27	1	4	2(4):59-63	DATE
asodahs-27	2	1	59	CARDINAL
asodahs-27	2	2	asian	NORP
asodahs-27	2	3	2022	CARDINAL
asodahs-27	2	4	kurmi	GPE
asodahs-27	2	5	rubeena khan	PERSON
asodahs-27	2	6	basant khare	PERSON
asodahs-27	2	7	anushree jain	GPE
asodahs-27	2	8	kumar jain	PERSON
asodahs-27	2	9	bhupendra	GPE
asodahs-27	2	10	singh	GPE
asodahs-27	2	11	adina campus	PERSON
asodahs-27	2	12	rd	GPE
asodahs-27	2	13	lahdara	GPE
asodahs-27	2	14	sagar	PERSON
asodahs-27	2	15	470001	DATE
asodahs-27	41	1	17	CARDINAL
asodahs-27	41	2	09 nov 2022	CARDINAL
asodahs-27	41	3	24 nov 2022	DATE
asodahs-27	41	4	15	CARDINAL
asodahs-27	79	1	kurmi g	ORG
asodahs-27	79	2	khan	GPE
asodahs-27	79	3	khare b	ORG
asodahs-27	79	4	jain pk	PERSON
asodahs-27	79	5	thakur bs	PERSON
asodahs-27	79	6	asian	NORP
asodahs-27	79	7	2022	CARDINAL
asodahs-27	79	8	2(4):59-63	DATE
asodahs-27	117	1	bhupendra singh thakur	PERSON
asodahs-27	117	2	adina college	ORG
asodahs-27	117	3	adina campus	PERSON
asodahs-27	117	4	rd	GPE
asodahs-27	117	5	lahdara	GPE
asodahs-27	117	6	sagar	PERSON
asodahs-27	117	7	470001	DATE
asodahs-27	232	1	discovery	PRODUCT
asodahs-27	233	1	around 12 years	DATE
asodahs-27	233	2	2.7 billion usd	MONEY
asodahs-27	235	1	discovery	PRODUCT
asodahs-27	236	1	discovery	PRODUCT
asodahs-27	238	1	discovery	PRODUCT
asodahs-27	238	2	discovery	PRODUCT
asodahs-27	239	1	more than 200	CARDINAL
asodahs-27	239	2	first	ORDINAL
asodahs-27	240	1	the 21st century	DATE
asodahs-27	241	1	the world health organization	ORG
asodahs-27	241	2	2015	DATE
asodahs-27	241	3	second	ORDINAL
asodahs-27	241	4	70 years old	DATE
asodahs-27	241	5	91	CARDINAL
asodahs-27	241	6	third	ORDINAL
asodahs-27	241	7	fourth	ORDINAL
asodahs-27	241	8	22	CARDINAL
asodahs-27	241	9	countries1	PERSON
asodahs-27	242	1	18.1 million	CARDINAL
asodahs-27	242	2	9.6 million	CARDINAL
asodahs-27	242	3	study2	LOC
asodahs-27	242	4	70%	PERCENT
asodahs-27	246	1	12 years	DATE
asodahs-27	246	2	investment3	PERSON
asodahs-27	248	1	1997	DATE
asodahs-27	248	2	first	ORDINAL
asodahs-27	248	3	structure4	PERSON
asodahs-27	250	1	applications7	ORG
asodahs-27	254	1	approximately 30,000	CARDINAL
asodahs-27	254	2	around 6,000	CARDINAL
asodahs-27	254	3	8,000	CARDINAL
asodahs-27	255	1	less than 400	CARDINAL
asodahs-27	255	2	http://jddtonline.info/ http://dx.doi.org/10.22270/ajdhs.v2i4.27	PERSON
asodahs-27	255	3	al asian journal	ORG
asodahs-27	255	4	2022	CARDINAL
asodahs-27	255	5	2(4):59-63	DATE
asodahs-27	256	1	60	CARDINAL
asodahs-27	256	2	now8,9	ORG
asodahs-27	257	1	one	CARDINAL
asodahs-27	257	2	one	CARDINAL
asodahs-27	258	1	proteins11	GPE
asodahs-27	261	1	one	CARDINAL
asodahs-27	265	1	ras	ORG
asodahs-27	271	1	chen et al	PERSON
asodahs-27	273	1	attention16	ORG
asodahs-27	274	1	fda	ORG
asodahs-27	274	2	targets15	GPE
asodahs-27	275	1	first	ORDINAL
asodahs-27	276	1	2010	DATE
asodahs-27	276	2	klipp et al	ORG
asodahs-27	278	1	method18	ORG
asodahs-27	278	2	bipartite	ORG
asodahs-27	278	3	method19	ORG
asodahs-27	279	1	mayr et al	PERSON
asodahs-27	284	1	qsar	PERSON
asodahs-27	285	1	multi linear	ORG
asodahs-27	287	1	discovery	PRODUCT
asodahs-27	288	1	2d	CARDINAL
asodahs-27	289	1	3d	CARDINAL
asodahs-27	289	2	analysis24	GPE
asodahs-27	289	3	analysis25	GPE
asodahs-27	290	1	3d	CARDINAL
asodahs-27	294	1	alomori et al.	PERSON
asodahs-27	294	2	four	CARDINAL
asodahs-27	301	1	two	CARDINAL
asodahs-27	302	1	2h2o	CARDINAL
asodahs-27	303	1	al asian journal	ORG
asodahs-27	303	2	2022	CARDINAL
asodahs-27	303	3	2(4):59-63	DATE
asodahs-27	303	4	61	CARDINAL
asodahs-27	305	1	0.97	CARDINAL
asodahs-27	306	1	2h2o	CARDINAL
asodahs-27	307	1	drug26	ORG
asodahs-27	308	1	hdac3	ORG
asodahs-27	308	2	first	ORDINAL
asodahs-27	308	3	hdac3	ORG
asodahs-27	308	4	hdac1	ORG
asodahs-27	308	5	hdac2	ORG
asodahs-27	309	1	hdac3	ORG
asodahs-27	310	1	hdac3	ORG
asodahs-27	311	1	hdac1	ORG
asodahs-27	311	2	hdac2	ORG
asodahs-27	312	1	hdac3	ORG
asodahs-27	312	2	hdac1	ORG
asodahs-27	313	1	hdac3	ORG
asodahs-27	313	2	hdac2	ORG
asodahs-27	314	1	hdac3	ORG
asodahs-27	315	1	ahirwar et	PERSON
asodahs-27	315	2	al asian journal	ORG
asodahs-27	315	3	2022	CARDINAL
asodahs-27	315	4	2(4):59-63	DATE
asodahs-27	316	1	62	CARDINAL
asodahs-27	316	2	two	CARDINAL
asodahs-27	316	3	3d	CARDINAL
asodahs-27	316	4	7.32	CARDINAL
asodahs-27	316	5	9.92	CARDINAL
asodahs-27	316	6	7.32	CARDINAL
asodahs-27	316	7	9.92	CARDINAL
asodahs-27	316	8	42	CARDINAL
asodahs-27	318	1	lipinski	PERSON
asodahs-27	318	2	veber	DATE
asodahs-27	318	3	ghose	GPE
asodahs-27	319	1	t1-t5	ORG
asodahs-27	319	2	1	CARDINAL
asodahs-27	320	1	activity28	ORG
asodahs-27	322	1	about 9.6 million	CARDINAL
asodahs-27	322	2	each year	DATE
asodahs-27	323	1	second	ORDINAL
asodahs-27	324	1	12 years	DATE
asodahs-27	324	2	2.7 billion usd	MONEY
asodahs-27	329	1	recent years	DATE
asodahs-27	331	1	1	CARDINAL
asodahs-27	332	1	yang w	PERSON
asodahs-27	332	2	han x	PERSON
asodahs-27	332	3	han l. crystal	PERSON
asodahs-27	332	4	two	CARDINAL
asodahs-27	334	1	2019	DATE
asodahs-27	334	2	18(3):239246	DATE
asodahs-27	335	1	2	CARDINAL
asodahs-27	335	2	bray f	PERSON
asodahs-27	335	3	soerjomataram	PERSON
asodahs-27	335	4	siegel rl	PERSON
asodahs-27	335	5	torre la	PERSON
asodahs-27	335	6	jemal a. global cancer statistics	PERSON
asodahs-27	335	7	2018	DATE
asodahs-27	335	8	36	CARDINAL
asodahs-27	335	9	185	CARDINAL
asodahs-27	337	1	2018	DATE
asodahs-27	337	2	68(6):394-424	CARDINAL
asodahs-27	338	1	3	CARDINAL
asodahs-27	338	2	kapetanovic i.	PERSON
asodahs-27	339	1	2008	DATE
asodahs-27	339	2	171(2):165	CARDINAL
asodahs-27	340	1	4	CARDINAL
asodahs-27	340	2	kaldor sw	PERSON
asodahs-27	340	3	kalish vj	PERSON
asodahs-27	340	4	davies jf	PERSON
asodahs-27	340	5	shetty bv	PERSON
asodahs-27	340	6	fritz je	PERSON
asodahs-27	340	7	appelt k	PERSON
asodahs-27	340	8	tatlock jh	PERSON
asodahs-27	341	1	viracept	PERSON
asodahs-27	341	2	ag1343	ORG
asodahs-27	343	1	1997	DATE
asodahs-27	343	2	40(24):3979-3985	DATE
asodahs-27	345	1	chan hs	PERSON
asodahs-27	345	2	shan h	GPE
asodahs-27	345	3	vogel h	ORG
asodahs-27	345	4	yuan s. advancing drug	PERSON
asodahs-27	347	1	2019	DATE
asodahs-27	347	2	40(8):592-604	CARDINAL
asodahs-27	348	1	6	CARDINAL
asodahs-27	349	1	yang w	PERSON
asodahs-27	349	2	han x	PERSON
asodahs-27	349	3	han l. crystal	PERSON
asodahs-27	349	4	two	CARDINAL
asodahs-27	351	1	2019	DATE
asodahs-27	351	2	18(3):239246	DATE
asodahs-27	353	1	zhavoronkov	PERSON
asodahs-27	353	2	ivanenkov ya	PERSON
asodahs-27	353	3	aladinskiy va	GPE
asodahs-27	353	4	aladinskaya av	PERSON
asodahs-27	353	5	guzik a. deep	PERSON
asodahs-27	353	6	ddr1	ORG
asodahs-27	355	1	2019	CARDINAL
asodahs-27	355	2	37(9):1038	CARDINAL
asodahs-27	356	1	8	CARDINAL
asodahs-27	357	1	drews j. drug	PERSON
asodahs-27	359	1	2000	DATE
asodahs-27	359	2	287(5460):1960-1964	DATE
asodahs-27	361	1	chen x	PERSON
asodahs-27	361	2	yan cc	PERSON
asodahs-27	361	3	zhang x	PERSON
asodahs-27	361	4	zhang x	PERSON
asodahs-27	361	5	dai	ORG
asodahs-27	361	6	zhang y. drug	PERSON
asodahs-27	363	1	2016	CARDINAL
asodahs-27	363	2	17(4):696-712	CARDINAL
asodahs-27	364	1	https://doi.org/10.1093/bib/bbv066	ORG
asodahs-27	367	1	annual	DATE
asodahs-27	368	1	2016	CARDINAL
asodahs-27	368	2	56:23-40	DATE
asodahs-27	369	1	https://doi.org/10.1146/annurev-pharmtox-010715103440 11	ORG
asodahs-27	370	1	al	PERSON
asodahs-27	372	1	2008	DATE
asodahs-27	372	2	4(11):682-690	CARDINAL
asodahs-27	374	1	12	CARDINAL
asodahs-27	375	1	araki m	PERSON
asodahs-27	375	2	honda	ORG
asodahs-27	375	3	w	PRODUCT
asodahs-27	375	4	kanehisa m. prediction of	PERSON
asodahs-27	376	1	2008	DATE
asodahs-27	376	2	24(13):i232	CARDINAL
asodahs-27	376	3	13	CARDINAL
asodahs-27	377	1	rajak	PERSON
asodahs-27	377	2	jain dk	PERSON
asodahs-27	377	3	dewangan pk	PERSON
asodahs-27	377	4	gupta ak	ORG
asodahs-27	378	1	1	CARDINAL
asodahs-27	378	2	3	DATE
asodahs-27	378	3	4	CARDINAL
asodahs-27	379	1	2012	DATE
asodahs-27	379	2	148	CARDINAL
asodahs-27	380	1	14	CARDINAL
asodahs-27	381	1	ghofrani	PERSON
asodahs-27	381	2	f. sildenafil	PERSON
asodahs-27	383	1	2006	DATE
asodahs-27	383	2	5(8):689-702	CARDINAL
asodahs-27	384	1	https://doi.org/10.1038/nrd2030 https://doi.org/10.3233/mgc-180748	PERSON
asodahs-27	386	1	https://doi.org/10.1146/annurev-pharmtox-010715-103440	ORG
asodahs-27	386	2	https://doi.org/10.1146/annurev-pharmtox-010715-103440	ORG
asodahs-27	386	3	https://doi.org/10.1038/nrd2030 ahirwar et	PERSON
asodahs-27	386	4	al asian journal	ORG
asodahs-27	386	5	2022	CARDINAL
asodahs-27	386	6	2(4):59-63	DATE
asodahs-27	387	1	63	CARDINAL
asodahs-27	387	2	15	CARDINAL
asodahs-27	388	1	takarabe m	PERSON
asodahs-27	388	2	kotera m	PERSON
asodahs-27	388	3	nishimura	ORG
asodahs-27	390	1	2012	DATE
asodahs-27	390	2	28(18):i611i618	DATE
asodahs-27	391	1	16	CARDINAL
asodahs-27	392	1	campillos m	PERSON
asodahs-27	392	2	kuhn m	PERSON
asodahs-27	392	3	gavin ac	PERSON
asodahs-27	392	4	jensen lj	PERSON
asodahs-27	392	5	bork p. drug	PERSON
asodahs-27	393	1	2008	DATE
asodahs-27	393	2	321(5886):263-266	CARDINAL
asodahs-27	393	3	17	CARDINAL
asodahs-27	394	1	klipp e, wade rc	ORG
asodahs-27	394	2	kummer u. biochemical network	ORG
asodahs-27	396	1	2010	DATE
asodahs-27	396	2	21(4):511-516	CARDINAL
asodahs-27	397	1	18	CARDINAL
asodahs-27	398	1	srivastava n	PERSON
asodahs-27	398	2	hinton g	PERSON
asodahs-27	398	3	krizhevsky	PERSON
asodahs-27	400	1	2014	DATE
asodahs-27	400	2	15(1):1929-1958	DATE
asodahs-27	401	1	19	CARDINAL
asodahs-27	401	2	li x	PERSON
asodahs-27	401	3	chen h.	PERSON
asodahs-27	401	4	bipartite	ORG
asodahs-27	403	1	2013	DATE
asodahs-27	403	2	54(2):880-890	QUANTITY
asodahs-27	404	1	20	CARDINAL
asodahs-27	404	2	yıldırım ma	PERSON
asodahs-27	404	3	goh ki	PERSON
asodahs-27	404	4	cusick	PERSON
asodahs-27	404	5	al, vidal m. drug-target network	ORG
asodahs-27	406	1	2007	DATE
asodahs-27	406	2	25(10):1119-1126	CARDINAL
asodahs-27	407	1	21	CARDINAL
asodahs-27	408	1	mayr	PERSON
asodahs-27	408	2	wegner jk	PERSON
asodahs-27	408	3	ceulemans h	ORG
asodahs-27	408	4	hochreiter s. large-scale	PERSON
asodahs-27	410	1	2018	DATE
asodahs-27	410	2	9(24):5441-5451	DATE
asodahs-27	411	1	22	CARDINAL
asodahs-27	412	1	mendenhall j	PERSON
asodahs-27	414	1	2016	CARDINAL
asodahs-27	414	2	30(2):177	CARDINAL
asodahs-27	414	3	189	CARDINAL
asodahs-27	415	1	23	CARDINAL
asodahs-27	416	1	hansch c	PERSON
asodahs-27	416	2	fujita t. additions	PERSON
asodahs-27	418	1	american	NORP
asodahs-27	419	1	1964	DATE
asodahs-27	419	2	86(24):5710-5710	CARDINAL
asodahs-27	420	1	24	CARDINAL
asodahs-27	421	1	cramer rd	ORG
asodahs-27	421	2	patterson de	PERSON
asodahs-27	421	3	bunce jd	PERSON
asodahs-27	422	1	1	CARDINAL
asodahs-27	423	1	american	NORP
asodahs-27	424	1	1998	DATE
asodahs-27	424	2	110(18):5959-5967	DATE
asodahs-27	425	1	25	CARDINAL
asodahs-27	426	1	klebe g	PERSON
asodahs-27	426	2	abraham u	PERSON
asodahs-27	428	1	1994	DATE
asodahs-27	428	2	37(24):4130-4146	DATE
asodahs-27	429	1	26	CARDINAL
asodahs-27	430	1	alomari fy	PERSON
asodahs-27	430	2	sharfalddin aa	PERSON
asodahs-27	430	3	domyati	ORG
asodahs-27	430	4	hussien ma	PERSON
asodahs-27	430	5	qsar	PERSON
asodahs-27	432	1	2022	CARDINAL
asodahs-27	432	2	27(3):649	DATE
asodahs-27	434	1	adhikari n	PERSON
asodahs-27	434	2	amin sa	PERSON
asodahs-27	434	3	trivedi p	ORG
asodahs-27	434	4	jha t	PERSON
asodahs-27	434	5	b. hdac3	PERSON
asodahs-27	434	6	hdac3	ORG
asodahs-27	435	1	european journal of medicinal chemistry	ORG
asodahs-27	436	1	2018	DATE
asodahs-27	437	1	157:1127-1142	CARDINAL
asodahs-27	438	1	28	CARDINAL
asodahs-27	439	1	singh	GPE
asodahs-27	439	2	jain dk	GPE
asodahs-27	439	3	sharma pc	PERSON
asodahs-27	439	4	gupta ak	ORG
asodahs-27	439	5	sharma ak	ORG
asodahs-27	439	6	rajak h. histone deacetylase	PERSON
asodahs-27	441	1	2013	DATE
asodahs-27	441	2	03	CARDINAL
asodahs-27	441	3	04):102-107	CARDINAL
asodahs-27	441	4	https://doi.org/10.1039/c8sc00148k	PRODUCT
asodahs-27	442	1	https://doi.org/10.3390/molecules27030649 https://doi.org/10.1016/j.ejmech.2018.08.081	PRODUCT